These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 14985492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Infliximab in fistulizing Crohn's disease.
    Osterman MT, Lichtenstein GR.
    Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
    [Abstract] [Full Text] [Related]

  • 4. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.
    Sands BE, Blank MA, Diamond RH, Barrett JP, Van Deventer SJ.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1127-36. PubMed ID: 16611273
    [Abstract] [Full Text] [Related]

  • 5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T, Göke B, Sackmann M.
    Am J Gastroenterol; 2002 Aug 15; 97(8):2022-5. PubMed ID: 12190171
    [Abstract] [Full Text] [Related]

  • 6. Infliximab maintenance therapy for fistulizing Crohn's disease.
    Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ.
    N Engl J Med; 2004 Feb 26; 350(9):876-85. PubMed ID: 14985485
    [Abstract] [Full Text] [Related]

  • 7. How to improve the safety of biologic therapy in Crohn's disease.
    Ferkolj I.
    J Physiol Pharmacol; 2009 Dec 26; 60 Suppl 7():67-70. PubMed ID: 20388947
    [Abstract] [Full Text] [Related]

  • 8. [What can be expected from biological therapies for Crohn's disease?].
    Lemann M.
    Gastroenterol Clin Biol; 2001 Nov 26; 25(11):945-7. PubMed ID: 11845043
    [No Abstract] [Full Text] [Related]

  • 9. [Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
    Heidemann J, Kucharzik T.
    Z Gastroenterol; 2005 Jul 26; 43(7):689-90. PubMed ID: 16001352
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment with chimeric monoclonal antitumor necrosis factor (infliximab) of patients with active steroid-dependent/resistant Crohn's disease and fistulas].
    Martorana G, Casà A, Oliva L, Orlando A, Cottone M.
    Recenti Prog Med; 2001 Jul 26; 92(7-8):451-5. PubMed ID: 11475786
    [Abstract] [Full Text] [Related]

  • 11. Balancing the risks and benefits of prolonged use of infliximab.
    Schölmerich J.
    Gut; 2009 Apr 26; 58(4):477-8. PubMed ID: 19299379
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR.
    Am J Gastroenterol; 2005 Jul 26; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract] [Full Text] [Related]

  • 15. Prediction of response to infliximab in Crohn's disease.
    Chaudhary R, Ghosh S.
    Dig Liver Dis; 2005 Aug 26; 37(8):559-63. PubMed ID: 15893967
    [No Abstract] [Full Text] [Related]

  • 16. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
    Ben Hriz F, Habbessi H, Maamouri N, Belkahla N, Ouerdiane S, Chouaib S, Ouerghi H, Chaabouni H, Ben Mami N.
    Tunis Med; 2009 Aug 26; 87(8):545-6. PubMed ID: 20180364
    [No Abstract] [Full Text] [Related]

  • 17. Complete resolution of enterocolic fistulas with infliximab.
    Nunes J, Santos PM, Tavares L.
    BioDrugs; 2010 Dec 14; 24 Suppl 1():28-30. PubMed ID: 21175233
    [Abstract] [Full Text] [Related]

  • 18. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV.
    Am J Gastroenterol; 2005 Jul 14; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract] [Full Text] [Related]

  • 19. Perianal Crohn's disease (Br J Surg 2004; 91: 801-814).
    Olaison G, Almer S, Anderson P.
    Br J Surg; 2004 Oct 14; 91(10):1381. PubMed ID: 15382098
    [No Abstract] [Full Text] [Related]

  • 20. Infliximab use in luminal Crohn's disease.
    Richter JA, Bickston SJ.
    Gastroenterol Clin North Am; 2006 Dec 14; 35(4):775-93. PubMed ID: 17129813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.